HSBC analyst Phani Kanumuri upgraded Endava to Buy from Hold with a price target of $45, up from $44. The firm sees EPS bottoming out in Q3 as cost optimization measures should start impacting net income positively, says the Equiniti deal “increases our conviction that Endava could defend its revenue base,” argues the acquisition of GalaxE should help reduce industry and geography concentration risk and boost growth and adds that the valuation “looks very attractive.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava price target lowered to $33 from $40 at Citi
- Endava PLC: Earnings Dip Amidst Financial Turnaround
- ‘The Tip of the Spear’: These 2 IT Service Stocks Are Poised to Benefit From an AI-Driven Technology Cycle, Says Analyst
- Endava upgraded to Overweight from Neutral at JPMorgan
- Endava initiated with a Buy at Guggenheim
Questions or Comments about the article? Write to editor@tipranks.com